LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 69

Search options

  1. Article ; Online: Estimating the prevalence of two or more diseases using outcomes from multiplex group testing.

    Warasi, Md S / Tebbs, Joshua M / McMahan, Christopher S / Bilder, Christopher R

    Biometrical journal. Biometrische Zeitschrift

    2023  Volume 65, Issue 7, Page(s) e2200270

    Abstract: ... of Iowa to illustrate our work. We also provide an online R resource practitioners can use to implement ...

    Abstract When screening a population for infectious diseases, pooling individual specimens (e.g., blood, swabs, urine, etc.) can provide enormous cost savings when compared to testing specimens individually. In the biostatistics literature, testing pools of specimens is commonly known as group testing or pooled testing. Although estimating a population-level prevalence with group testing data has received a large amount of attention, most of this work has focused on applications involving a single disease, such as human immunodeficiency virus. Modern methods of screening now involve testing pools and individuals for multiple diseases simultaneously through the use of multiplex assays. Hou et al. (2017, Biometrics, 73, 656-665) and Hou et al. (2020, Biostatistics, 21, 417-431) recently proposed group testing protocols for multiplex assays and derived relevant case identification characteristics, including the expected number of tests and those which quantify classification accuracy. In this article, we describe Bayesian methods to estimate population-level disease probabilities from implementing these protocols or any other multiplex group testing protocol which might be carried out in practice. Our estimation methods can be used with multiplex assays for two or more diseases while incorporating the possibility of test misclassification for each disease. We use chlamydia and gonorrhea testing data collected at the State Hygienic Laboratory at the University of Iowa to illustrate our work. We also provide an online R resource practitioners can use to implement the methods in this article.
    MeSH term(s) Humans ; Chlamydia Infections/diagnosis ; Chlamydia Infections/epidemiology ; Chlamydia Infections/prevention & control ; Bayes Theorem ; Prevalence ; Communicable Diseases/diagnosis ; Communicable Diseases/epidemiology ; Probability
    Language English
    Publishing date 2023-05-16
    Publishing country Germany
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 131640-0
    ISSN 1521-4036 ; 0323-3847 ; 0006-3452
    ISSN (online) 1521-4036
    ISSN 0323-3847 ; 0006-3452
    DOI 10.1002/bimj.202200270
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Discussion on "Is group testing ready for prime-time in disease identification".

    Bilder, Christopher R / Tebbs, Joshua M / McMahan, Christopher S

    Statistics in medicine

    2021  Volume 40, Issue 17, Page(s) 3881–3886

    Language English
    Publishing date 2021-02-12
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S. ; Comment
    ZDB-ID 843037-8
    ISSN 1097-0258 ; 0277-6715
    ISSN (online) 1097-0258
    ISSN 0277-6715
    DOI 10.1002/sim.8988
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Informative array testing with multiplex assays.

    Bilder, Christopher R / Tebbs, Joshua M / McMahan, Christopher S

    Statistics in medicine

    2021  Volume 40, Issue 13, Page(s) 3021–3034

    Abstract: ... provide R functions to make our research accessible to laboratories. ...

    Abstract High-volume testing of clinical specimens for sexually transmitted diseases is performed frequently by a process known as group testing. This algorithmic process involves testing portions of specimens from separate individuals together as one unit (or "group") to detect diseases. Retesting is performed on groups that test positively in order to differentiate between positive and negative individual specimens. The overall goal is to use the least number of tests possible across all individuals without sacrificing diagnostic accuracy. One of the most efficient group testing algorithms is array testing. In its simplest form, specimens are arranged into a grid-like structure so that row and column groups can be formed. Positive-testing rows/columns indicate which specimens to retest. With the growing use of multiplex assays, the increasing number of diseases tested by these assays, and the availability of subject-specific risk information, opportunities exist to make this testing process even more efficient. We propose specific specimen arrangements within an array that can reduce the number of retests needed when compared with other array testing algorithms. We examine how to calculate operating characteristics, including the expected number of tests and the SD for the number of tests, and then subsequently find a best arrangement. Our methods are illustrated for chlamydia and gonorrhea detection with the Aptima Combo 2 Assay. We also provide R functions to make our research accessible to laboratories.
    MeSH term(s) Algorithms ; Chlamydia Infections ; Chlamydia trachomatis ; Gonorrhea ; Humans ; Sensitivity and Specificity ; Sexually Transmitted Diseases
    Language English
    Publishing date 2021-03-24
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 843037-8
    ISSN 1097-0258 ; 0277-6715
    ISSN (online) 1097-0258
    ISSN 0277-6715
    DOI 10.1002/sim.8954
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Pool Size Selection When Testing for Severe Acute Respiratory Syndrome Coronavirus 2.

    Bilder, Christopher R / Iwen, Peter C / Abdalhamid, Baha

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2020  Volume 72, Issue 6, Page(s) 1104–1105

    MeSH term(s) COVID-19 ; COVID-19 Testing ; Female ; Humans ; SARS-CoV-2 ; Sample Size
    Keywords covid19
    Language English
    Publishing date 2020-06-09
    Publishing country United States
    Document type Letter ; Research Support, N.I.H., Extramural
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciaa774
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Tests in short supply? Try group testing.

    Bilder, Christopher R / Iwen, Peter C / Abdalhamid, Baha / Tebbs, Joshua M / McMahan, Christopher S

    Significance (Oxford, England)

    2020  Volume 17, Issue 3, Page(s) 15–16

    Abstract: Christopher R. Bilder, Peter C. Iwen, Baha Abdalhamid, Joshua M. Tebbs ...

    Abstract Christopher R. Bilder, Peter C. Iwen, Baha Abdalhamid, Joshua M. Tebbs
    Keywords covid19
    Language English
    Publishing date 2020-05-27
    Publishing country England
    Document type Journal Article
    ZDB-ID 2139469-6
    ISSN 1740-9713 ; 1740-9705
    ISSN (online) 1740-9713
    ISSN 1740-9705
    DOI 10.1111/1740-9713.01399
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Incorporating the dilution effect in group testing regression.

    Mokalled, Stefani C / McMahan, Christopher S / Tebbs, Joshua M / Andrew Brown, Derek / Bilder, Christopher R

    Statistics in medicine

    2021  Volume 40, Issue 11, Page(s) 2540–2555

    Abstract: When screening for infectious diseases, group testing has proven to be a cost efficient alternative to individual level testing. Cost savings are realized by testing pools of individual specimens (eg, blood, urine, saliva, and so on) rather than by ... ...

    Abstract When screening for infectious diseases, group testing has proven to be a cost efficient alternative to individual level testing. Cost savings are realized by testing pools of individual specimens (eg, blood, urine, saliva, and so on) rather than by testing the specimens separately. However, a common concern that arises in group testing is the so-called "dilution effect." This occurs if the signal from a positive individual's specimen is diluted past an assay's threshold of detection when it is pooled with multiple negative specimens. In this article, we propose a new statistical framework for group testing data that merges estimation and case identification, which are often treated separately in the literature. Our approach considers analyzing continuous biomarker levels (eg, antibody levels, antigen concentrations, and so on) from pooled samples to estimate both a binary regression model for the probability of disease and the biomarker distributions for cases and controls. To increase case identification accuracy, we then show how estimates of the biomarker distributions can be used to select diagnostic thresholds on a pool-by-pool basis. Our proposals are evaluated through numerical studies and are illustrated using hepatitis B virus data collected on a prison population in Ireland.
    MeSH term(s) Biomarkers ; Communicable Diseases ; Humans ; Ireland ; Mass Screening
    Chemical Substances Biomarkers
    Language English
    Publishing date 2021-02-17
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 843037-8
    ISSN 1097-0258 ; 0277-6715
    ISSN (online) 1097-0258
    ISSN 0277-6715
    DOI 10.1002/sim.8916
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Informative group testing for multiplex assays.

    Bilder, Christopher R / Tebbs, Joshua M / McMahan, Christopher S

    Biometrics

    2019  Volume 75, Issue 1, Page(s) 278–288

    Abstract: Infectious disease testing frequently takes advantage of two tools-group testing and multiplex assays-to make testing timely and cost effective. Until the work of Tebbs et al. (2013) and Hou et al. (2017), there was no research available to understand ... ...

    Abstract Infectious disease testing frequently takes advantage of two tools-group testing and multiplex assays-to make testing timely and cost effective. Until the work of Tebbs et al. (2013) and Hou et al. (2017), there was no research available to understand how best to apply these tools simultaneously. This recent work focused on applications where each individual is considered to be identical in terms of the probability of disease. However, risk-factor information, such as past behavior and presence of symptoms, is very often available on each individual to allow one to estimate individual-specific probabilities. The purpose of our paper is to propose the first group testing algorithms for multiplex assays that take advantage of individual risk-factor information as expressed by these probabilities. We show that our methods significantly reduce the number of tests required while preserving accuracy. Throughout this paper, we focus on applying our methods with the Aptima Combo 2 Assay that is used worldwide for chlamydia and gonorrhea screening.
    MeSH term(s) Algorithms ; Chlamydia Infections/diagnosis ; Communicable Diseases/diagnosis ; Female ; Gonorrhea/diagnosis ; Humans ; Male ; Mass Screening/methods ; Probability ; Risk Factors
    Language English
    Publishing date 2019-03-28
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 213543-7
    ISSN 1541-0420 ; 0099-4987 ; 0006-341X
    ISSN (online) 1541-0420
    ISSN 0099-4987 ; 0006-341X
    DOI 10.1111/biom.12988
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Human or Cylon?: Group testing on Battlestar Galactica.

    Bilder, Christopher R

    Chance (New York, N.Y.)

    2010  Volume 22, Issue 3, Page(s) 46–50

    Language English
    Publishing date 2010-07-21
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2478379-1
    ISSN 1867-2280 ; 0933-2480
    ISSN (online) 1867-2280
    ISSN 0933-2480
    DOI 10.1007/s00144-009-0030-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Generalized additive regression for group testing data.

    Liu, Yan / McMahan, Christopher S / Tebbs, Joshua M / Gallagher, Colin M / Bilder, Christopher R

    Biostatistics (Oxford, England)

    2020  Volume 22, Issue 4, Page(s) 873–889

    Abstract: In screening applications involving low-prevalence diseases, pooling specimens (e.g., urine, blood, swabs, etc.) through group testing can be far more cost effective than testing specimens individually. Estimation is a common goal in such applications ... ...

    Abstract In screening applications involving low-prevalence diseases, pooling specimens (e.g., urine, blood, swabs, etc.) through group testing can be far more cost effective than testing specimens individually. Estimation is a common goal in such applications and typically involves modeling the probability of disease as a function of available covariates. In recent years, several authors have developed regression methods to accommodate the complex structure of group testing data but often under the assumption that covariate effects are linear. Although linearity is a reasonable assumption in some applications, it can lead to model misspecification and biased inference in others. To offer a more flexible framework, we propose a Bayesian generalized additive regression approach to model the individual-level probability of disease with potentially misclassified group testing data. Our approach can be used to analyze data arising from any group testing protocol with the goal of estimating multiple unknown smooth functions of covariates, standard linear effects for other covariates, and assay classification accuracy probabilities. We illustrate the methods in this article using group testing data on chlamydia infection in Iowa.
    MeSH term(s) Bayes Theorem ; Chlamydia Infections/diagnosis ; Humans ; Mass Screening ; Prevalence ; Regression Analysis
    Language English
    Publishing date 2020-02-06
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2031500-4
    ISSN 1468-4357 ; 1465-4644
    ISSN (online) 1468-4357
    ISSN 1465-4644
    DOI 10.1093/biostatistics/kxaa003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top